|Articles|August 20, 2019

Prospectus For Establishment of a DSCSA Governance Body

Click on the link below to read the document:

Final Governance Prospectus Document_080919

Newsletter

Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

Subscribe

Related Content

Supply Chain Signal: Domestic Manufacturing and the German Pricing Standoff

ByThani Jambulingam, PhD,Stephen Appezzato

July 17th 2026

Cencora's Brent Wilhelm on the Inventory Paradox Behind Drug Shortages

ByBrent Wilhelm,Zachary Zubulake

July 17th 2026

Mid-Year Check-In: Will Pharma M&A Keep Pace?

ByRoel van den Akker,Stephen Appezzato

July 16th 2026

How Lilly's AtaiBeckley Deal Accelerates Psychedelic Drug Commercialization Push

ByStephen Appezzato

July 16th 2026

Pharma Pulse: CVS Credits TrumpRx to Deductibles, Germany Hikes Drug Rebates

ByStephen Appezzato

July 16th 2026

Prospectus For Establishment of a DSCSA Governance Body

Related Content

Supply Chain Signal: Domestic Manufacturing and the German Pricing Standoff

Cencora's Brent Wilhelm on the Inventory Paradox Behind Drug Shortages

Mid-Year Check-In: Will Pharma M&A Keep Pace?

How Lilly's AtaiBeckley Deal Accelerates Psychedelic Drug Commercialization Push

Pharma Pulse: CVS Credits TrumpRx to Deductibles, Germany Hikes Drug Rebates

Trending on Pharmaceutical Commerce

Supply Chain Signal: Domestic Manufacturing and the German Pricing Standoff

How Lilly's AtaiBeckley Deal Accelerates Psychedelic Drug Commercialization Push

Cencora's Brent Wilhelm on the Inventory Paradox Behind Drug Shortages

Mid-Year Check-In: Will Pharma M&A Keep Pace?

Q&A: What Will It Take to Reshore US Drug Manufacturing?